The clinical and public health problem of relapse despite primaquine therapy: case review of repeated relapses of Plasmodium vivax acquired in Papua New Guinea

BACKGROUND: Primaquine is the only drug available for preventing relapse following a primary attack by Plasmodium vivax malaria. This drug imposes several important problems: daily dosing over two weeks; toxicity in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency; partner blood sch...

Descripción completa

Detalles Bibliográficos
Autores principales: Ingram, R Joan H, Crenna-Darusallam, Chelzie, Soebianto, Saraswati, Noviyanti, Rintis, Baird, J Kevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295472/
https://www.ncbi.nlm.nih.gov/pubmed/25495607
http://dx.doi.org/10.1186/1475-2875-13-488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295472/
https://www.ncbi.nlm.nih.gov/pubmed/25495607
http://dx.doi.org/10.1186/1475-2875-13-488

Ejemplares similares